Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of ...
Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.
In a small cohort of patients with Cushing’s disease, most had their urinary free cortisol normalized after being ...
Vertex Pharmaceuticals Incorporated’s $10B Crinetics Pharmaceuticals, Inc. buy adds PALSONIFY & a Phase 3 CAH asset. Click for more on VRTZX and CRNX stock.
Vertex Pharmaceuticals Incorporated VRTX on Monday agreed to acquire Crinetics Pharmaceuticals Inc. CRNX for $85 per share in cash, a total equity value of approximately $10 billion ($8.8 billion net ...
Vertex Pharmaceuticals Incorporated announced Monday it will acquire Crinetics Pharmaceuticals, Inc. for $85.00 per share in cash, representing a total equity value of approximately $10.0 billion, or ...
Recent advancements have changed the treatment paradigm in congenital adrenal hyperplasia. Treatment options for CAH differ for children vs. adults as treatment goals shift. In the past few years, ...
Beta-blockers, like propranolol, are often the first choice for treating essential tremor. Anti-seizure medications can help reduce muscle shaking by altering brain activity. Benzodiazepines can ease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results